spacer
home > ict > Spring 2012
PUBLICATIONS

International Clinical Trials

ict
Spring 2012

   
Text
PDF

Dr Graham Hughes reflects on the importance of clinical trial sample storage.

 
view
download pdf
bullet
Regulatory & Business Practice

Quality Oversight Programmes

High Standards

Third-party quality oversight programmes provide sponsors with an impartial assessment of their study, which can help to reduce costs and ensure regulatory standards are being met, as John R Wilson Jr at Beaufort, LLC discusses.

 
view
download pdf

Medical Devices

Off to Market

Karen Lunde and Stephan Joeken of CERES, Clinical Evaluation & Research share their thoughts on how best to compile a clinical investigation report to gain CE approval for a medical device.

 
view
download pdf

Cancer Drug Development

Data is King

Todd Clark at Value of Insight Consulting explains how the requirements of the FDA approval process can aid the development of cancer drugs by gathering information on endpoints, timelines, populations and safety results.

 
view
download pdf
bullet
Clinical Trial Management

Clinical Trial Management

Efficient Beginnings

The development of comprehensive risk and contingency plans, as well as sound communication plans, is essential when setting up a global clinical trial, as Kellie Malloy at PharmaNet/i3 explains.

 
view
download pdf
bullet
Clinical Trial Outsourcing

Outsourcing

The Art of Listening

Maintaining an equal and open relationship between sponsor and service provider can help ease the clinical trial process and encourage innovation, as Andy Thurstan of MD Events explores.

 
view
download pdf
bullet
eCLINICAL

Electronic Document Management Systems

Know Your Numbers

Rhonda J Paz and Diandra Nuno-Salcido of GuideStar Clinical Trials Management suggest how the formation of a regulatory document can benefit from adopting the right electronic document management system.

 
view
download pdf

Clinical Trial Applications

Submission Statement

Helle Ørbæk and Lillan Rejkjær of IWA Consulting explain how electroniccompatible clinical documentation provides an efficient and cost-effective method for submitting regulatory documents.

 
view
download pdf
bullet
Clinical Trial Supply & Packaging

Clinical Trial Labelling

Designer Label

Global clinical trials pose considerable challenges to the labelling process. Pernille Smith of CCL Label Healthcare discusses the methods being employed to overcome these difficulties.

 
view
download pdf
bullet
PREVIEW

Phase 1 and 2a Clinical Trials

Graham Hughes reviews the key presentations on proof of concept and venture capitalism at the London conference.

 
view
download pdf

Sample Management Strategy

Learn how successful sample management can help support the development of new therapies at the Global Sample Management Benchmarking Symposium.

 
view
download pdf
bullet
Regional trials

Regional Trials: South-East Asia

SEA Power

Kenneth Lee and Helen Neal at PRA consider the growth of clinical research in South-East Asia, and suggest that understanding the unique challenges of the region is essential.

 
view
download pdf

Hardware Fulfilment

Tools of the Trade

Karen Harley of Bracket and Christopher Nightingale describe how knowledge of local restrictions and regulations is critical when shipping hardware for a clinical trial, helping to prevent costly delays to the study.

 
view
download pdf
bullet
Central Labs

Central Laboratories

Rising to the Challenge

As the clinical research sector expands and trials become increasingly complex, central laboratories must learn to adapt to new pressures, as Graham Hughes and Richard Barrett, Consultants in Pharmaceutical Development discuss.

 
view
download pdf
bulletMetrics Champion Consortium

Metrics Champion Consortium

From Evolution to Revolution

Guy A Mascaro of the Metrics Champion Consortium explains the role that the organisation is playing in helping sponsors to improve the clinical research process.

 
view
download pdf

Trial Design

Adaptive Designs: Early Phase Trials

Keys to Successful Design

Denis Gossen and Dominique Demolle of Aepodia explain how, with adequate planning, adaptive trial designs in early phase research can help to improve accuracy and efficiency.

 
view
download pdf

Patient Recruitment and Retention

Post-Marketing Research

Planting the Seed

Post-marketing research (PMR) is growing in importance, with regulatory authorities increasingly requiring studies that confirm the ongoing safety of a newly-approved drug. Thomas Wagner of Trilogy Writing & Consulting advises on how to design a successful PMR plan.

 
view
download pdf

Patient-Friendly Trials

Home is Where the Trial is

Home trials can be difficult to set up, but Graham Wylie of the Medical Research Network suggests that these studies are worth the risk as they offer considerable benefits to patient recruitment and retention.

 
view
download pdf

Interview

Industry Interview

Thinking Allowed

ICT talks to Steve Cutler of ICON Clinical Research Services about his views on the clinical trials industry and how it might develop in the future.

 
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November

News and Press Releases

Kloeckner Pentaplast Announces Plans for New Lamination Facility


More info >>

White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

Industry Events

7th annual Orphan Drugs and Rare Diseases UK

18-19 October 2017, Holiday Inn Kensington Forum, London

SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement